Growing demand for predictive testing will fuel the demand for genetic testing in the upcoming years

The global genetic testing market is projected to grow at a considerable CAGR during the forecast period. Predictive testing is expected to witness significant growth during the forecast period, mainly due to increasing awareness related to available tests. Besides, the demand for genetic testing is increasing across the globe owing to the availability of new tests as well as advancement in genetic testing techniques. The companies offer innovative, efficient, and safer techniques of disease detection.

Browse the full report description of "Global Genetic Testing Market Size, Share & Trends Analysis Report by technology (Polymerase Chain Reaction, DNA sequencing, Cytogenetics (Karyotyping and FISH), Microarrays, Gene Expression Profiling) By Type (Prenatal and New-Born Genetic Testing, Predictive Testing, Diagnostic Testing, Carrier Testing, and Other) By Diseases (Cancer, Alzheimer’s and Parkinson, Fanconi Anaemia, Sickle Cell Anaemia, Cardiovascular Diseases, and Others), Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/genetic-testing-market

Cancer, which is among the most fatal disease globally can find the risk of developing some specific cancer by predictive testing. For instance, there are mutations of the BRCA-1 and BRCA-2 genes which exhibit the risk of developing breast and/or ovarian cancers among women. If a woman has a family history of these cancers, they can undergo a genetic test that would find the mutations of those specific genes. Another genetic testing related to predictive cancer testing includes Lynch syndrome, which is an inherited illness linked to colorectal cancer. Testing positive for this increases the risk of colorectal cancer among an individual. Most of these tests are not FDA approved and can be done "direct-to-consumer". In the upcoming years, these tests are expected to be regulated which will provide more accurate and safe testing to the people. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2020-2026
• Segment Covered- 

o By Technology

o By Type

o By Diseases 

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Abbott Laboratories, Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd., Illumina, Inc., and Thermo Fisher Scientific, Inc.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Genetic Testing Market Report Segment

By Technology 

• Polymerase Chain Reaction
• DNA Sequencing
• Cytogenetics (Karyotyping and FISH)
• Microarrays
• Gene expression profiling

By Type

• Prenatal and New-Born Genetic Testing
• Predictive Testing
• Diagnostic Testing
• Carrier Testing
• Other

By Diseases 

• Cancer
• Alzheimer’s and Parkinson's
• Sickle Cell Anaemia
• Fanconi Anaemia
• Cardiovascular Disease
• Others (Cystic Fibrosis, Duchenne's Muscular Dystrophy)

Global Genetic Testing Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/genetic-testing-market